Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of
Xin Wang1, Kamal Kant Sahu2, Jan Cerny3
1Department of Medicine, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, MA, USA.
Insights
Coronavirus disease 2019 (COVID-19) involves endothelial damage and complement activation, leading to blood clotting. This review explores the interplay between the complement system, coagulation, and endothelium in COVID-19 pathogenesis.
Area of Science:
- * Hematology
- * Immunology
- * Virology
Background:
- * Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a novel infectious disease with evolving understanding of its pathogenesis.
- * Beyond primary lung injury, moderate to severe COVID-19 cases exhibit endothelial damage and complement system activation.
- * This points towards a pro-coagulable state, suggesting a significant role for vascular and immune systems in disease progression.
Purpose of the Study:
- * To review existing literature on the involvement of the complement system and coagulation cascade in COVID-19.
- * To explore the interaction between these systems and the endothelium in the context of SARS-CoV-2 infection.
- * To discuss the potential of COVID-19 as a novel hematological syndrome.
Main Methods:
- * Comprehensive literature review of scientific articles and case studies.
- * Analysis of research focusing on the pathophysiology of COVID-19.
- * Synthesis of data regarding complement activation, coagulation, and endothelial dysfunction in SARS-CoV-2 infection.
Main Results:
- * Evidence suggests a significant interplay between the endothelium, complement activation, and immune response in COVID-19 pathogenesis.
- * Endothelial damage and complement activation contribute to a pro-coagulable state observed in many COVID-19 patients.
- * These findings highlight the critical role of the hematological system in the manifestation of severe COVID-19.
Conclusions:
- * The interaction between the complement system, coagulation cascade, and endothelium is a key factor in COVID-19 pathogenesis.
- * COVID-19 may present as a novel hematological syndrome due to its impact on these systems.
- * Further research is warranted to fully elucidate these complex interactions and develop targeted therapies.
Abstract:
Coronavirus disease-2019 (COVID-19) is a rapidly evolving health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a novel disease entity and we are in a learning phase with regards to the pathogenesis, disease manifestations, and therapeutics. In addition to the primary lung injury, many patients especially the ones with moderate to severe COVID-19 display evidence of endothelial damage, complement activation, which leads to a pro-coagulable state. While there are still missing links in our understanding, the interplay of endothelium, complement system activation, and immune response to the SARS-CoV-2 virus is a surprisingly major factor in COVID-19 pathogenesis. One could envision COVID-19 becoming a novel hematological syndrome. This review is to discuss the available literature with regards to the involvement of the complement system, and coagulation cascade and their interaction with endothelium.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
Complement System
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation